Janssen covid-19 vaccine

''The Johnson & Johnson covid-19 vaccine is a covid-19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, subsidiary of American company Johnson & Johnson. It is a viral vector vaccine based on a human adenovirus that has been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus that causes covid-19. The body's immune system responds to this spike protein to produce antibodies. The vaccine requires only one dose and does not need to be stored frozen''.

News

 * 06 Jul 2021, Politico.eu, Commission buys 37M more J&J coronavirus shots, At the end of June, the company had delivered only 14 million doses.
 * 02 Jul 2021, Politico.eu, J&J vaccine shows promise against Delta coronavirus variant in small lab study, A second study showed that immunity from its single shot vaccine lasts at least eight months, the drugmaker said.
 * 28 Jun 2021, Reuters.com, Booster may be needed for J&J shot as Delta variant spreads, some experts already taking them
 * 11 Jun 2021, Politico.com, FDA tells J&J to scrap 60 million vaccine doses made at troubled plant, The agency also cleared 10 million doses for use.
 * 28 May 2021, Politico.eu, UK OKs J&J coronavirus vaccine, It’s the fourth jab to be approved in the UK.
 * 26 May 2021, Politico.eu, Belgium restricts use of J&J coronavirus vaccine to over-41s after death, The country has asked the EMA to evaluate whether the jab and the death were linked.
 * 10 May 2021, Politico.eu, Norway advised to drop Oxford/AstraZeneca and J&J from vaccine program, Neither viral vector vaccine is currently being used in the country.
 * 05 May 2021, (fr) FranceInfo.tv, Covid-19 : pourquoi le Danemark abandonne le vaccin de Johnson & Johnson, après celui d'AstraZeneca, Le Danemark a annoncé, lundi 3 mai, qu'il n'utiliserait pas le vaccin de Janssen, filiale du groupe américain Johnson & Johnson. En cause : le risque, même s'il est très faible, de thromboses atypiques, déjà pointé avec le vaccin d'AstraZeneca.
 * 25 Apr 2021, CDC.gov, CDC recommends use of Johnson & Johnson’s Janssen covid-19 vaccine resume
 * 24 Apr 2021, Politico.eu, US ends Johnson & Johnson vaccine pause, The Food and Drug Administration has amended the emergency use authorization for the vaccine to include mention of the clotting issue.
 * 23 Apr 2021, Reuters.com, Swedish health agency extends pause on J&J vaccine
 * 23 Apr 2021, FinancialPost.com, Germany sets no limits on use of J&J covid-19 shot
 * 20 Apr 2021, Politico.eu, EU regulator’s decision opens door for rollout of J&J vaccine, The Netherlands is among the countries that will now start using the jab.
 * 20 Apr 2021, Politico.eu, EU regulator: Johnson & Johnson vaccine is safe, may be linked to blood clots, All cases occurred in people under 60 years within three weeks of vaccination, the majority in women.
 * 16 Apr 2021, CDC.gov, Recommendation to pause use of Johnson & Johnson’s Janssen covid-19 vaccine, If you got this vaccine, seek medical care urgently if you develop any of the following symptoms 
 * 14 Apr 2021, Politico.eu, EU guidance on J&J jab coming next week, on Oxford/AstraZeneca later, To date, most EU countries have said they plan to use their J&J doses unless told otherwise by the EMA.
 * 14 Apr 2021, (fr) 7sur7.be, Johnson & Johnson demande à ne pas administrer le vaccin dans l’attente de la décision de l'EMA
 * 13 Apr 2021, Politico.eu, J&J vaccine suspension in US raises fears it’s the next AstraZeneca, So far, no EU countries said they would not use the vaccine — even if the company itself said it would pause the rollout.
 * 13 Apr 2021, Politico.eu, J&J delays European vaccine rollout over blood clotting concerns in US, The EU was set to start using the vaccine this week.
 * 13 Apr 2021, FDA.gov, Joint CDC and FDA Statement on Johnson & Johnson covid-19 vaccine, As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine.
 * 12 Apr 2021, Reuters.com, J&J begins covid-19 vaccine supplies to EU, 50 million doses expected in second quarter: lawmaker
 * 10 Apr 2021, TheEconomist.com, With millions vaccinated, rare side-effects of jabs are emerging, Johnson & Johnson’s vaccine is the latest to suffer a setback. The six blood clot cases investigated by American officials for the Johnson & Johnson jab were also accompanied by low platelet counts. They were all in women under 50, but that could be in large part because the jab has been widely used for essential workers who are predominantly women.
 * 29 Mar 2021, (fr) 7sur7.be, Janssen fournira jusqu'à 400 millions de doses de vaccin aux 55 pays membres de l'Union africaine, "Johnson & Johnson part du principe que personne n'est en sécurité tant que tout le monde n'est pas en sécurité. Nous nous engageons à un accès mondial équilibré aux nouveaux vaccins Covid-19", a déclaré Alex Gorsky, PDG de Johnson & Johnson.
 * 15 Mar 2021, Politico.eu, Johnson & Johnson picks German site for coronavirus vaccine production, The producer will use a site usually used for a dengue fever jab.
 * 12 Mar 2021, Politico.eu, WHO gives green light to J&J vaccine, This is the third vaccine to receive emergency use listing from the WHO, following Oxford/AstraZeneca and Pfizer/BioNTech.
 * 11 Mar 2021, Politico.eu, EU regulator recommends J&J coronavirus vaccine for use, The company will not start delivering doses to Europe until April.
 * 11 Mar 2021, (fr) LeSoir.be, Coronavirus: l’Agence européenne des médicaments donne son feu vert au vaccin de Johnson & Johnson, Le vaccin contre le coronavirus de Johnson & Johnson a reçu ce jeudi son autorisation de mise sur le marché UE
 * 10 Mar 2021, Politico.eu, Despite expected approval, J&J vaccine won’t fix EU’s supply crunch, The EU will approve its fourth vaccine Thursday, but it will take at least another three weeks to get doses.